| 【英語タイトル】Global Cell Banking Outsourcing Market Size study & Forecast, by Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), by Cell Type (Stem Cell Banking, Non-Stem Cell Banking), by Phase Outlook (Cell Bank Storage, Bank Characterization and Testing, Cell Bank Preparation) and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23FE0112
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年1月29日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：バイオ
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社の市場調査レポートでは、2021年に約9,869.5百万ドルであった世界のセルバンクアウトソーシング市場規模が、2022年から2029年の間に年平均16.39％成長する見込みです。当レポートは、セルバンクアウトソーシングの世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、バンク種類別（マスターセルバンク（MCB）、ワーキングセルバンク（WCB）、ウイルスセルバンク（VCB））分析、細胞種類別（幹細胞、非幹細胞）分析、フェーズアウトルック別（セルバンク保管、バンク特性評価・検査、セルバンク調製）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目を記載しています。並びに、市場調査の対象企業には、Tran-Scell Biologics Pvt Ltd、LifeCell International Pvt. Ltd、Cryo-Cell International, Inc.、BioReliance Corporation、SGA SA、Goodwin Biotechnology Inc.などが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界セルバンクアウトソーシング市場規模：バンク種類別
- マスターセルバンク（MCB）の市場規模
- ワーキングセルバンク（WCB）の市場規模
- ウイルスセルバンク（VCB）の市場規模
・世界セルバンクアウトソーシング市場規模：細胞種類別
- 幹細胞における市場規模
- 非幹細胞における市場規模
・世界セルバンクアウトソーシング市場規模：フェーズアウトルック別
- セルバンク保管における市場規模
- バンク特性評価・検査における市場規模
- セルバンク調製における市場規模
・世界のセルバンクアウトソーシング市場規模：地域別
- 北米のセルバンクアウトソーシング市場
- ヨーロッパのセルバンクアウトソーシング市場
- アジア太平洋のセルバンクアウトソーシング市場
- 中南米のセルバンクアウトソーシング市場
- その他地域のセルバンクアウトソーシング市場
・競争分析
・調査プロセス |
Global Cell Banking Outsourcing Market is valued at approximately USD 9869.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 16.39% over the forecast period 2022-2029. Cell banking is described as a procedure of replicating and preserving cells obtained from several body fluids and organ tissue for potential use in the future. The chief purpose of the preservation of these cell samples is to use them in research and surgical restoration of broken bodily parts. The most typical applications of cell banking are in stem cell analysis and treatment. Cell banking outsourcing plays a crucial role in the collection, characterization, storage, and testing of cell lines, cells, and tissues. The rising number of clinical trials for cell therapy, coupled with the increasing investments in drug and vaccine development are the primary factors that are surging the market demand across the globe.
In addition, the rising number of favorable government initiatives for the development of stable cell lines, and the augmentation of novel technologies are further impelling the market growth. For instance, in March 2019, Medical Research Future Fund Grant offer total funding of USD 150 million to the Australian Stem Therapies Mission with the objective of facilitating critical stem cell research. Likewise, in September 2021, California Institute for Regenerative Medicine provided Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA with total funding of USD 5 million in their research training program. Hence, these aforementioned factors are stipulating the demand for cell banking outsourcing in the global market, which, in turn, reinforces the market expansion. Moreover, growing research and development activities, as well as increasing approvals for cell therapies are presenting various lucrative opportunities over the forecasting years. However, the high storage cost is restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cell Banking Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market with revenue shares of USD 4071.7 million owing to the growing spending on research and development for drug development activities, rising focus on cancer research activities, organ transplants, and increasing approvals for cell therapies. Whereas, Asia Pacific is also expected to grow with the highest CAGR of 19.20% over the forecast period, owing to factors such as growing investment in drug development or discovery, rising government initiatives towards public health care, and rising prevalence of chronic diseases in the region.
Major market players included in this report are:
Tran-Scell Biologics Pvt Ltd
LifeCell International Pvt. Ltd
Cryo-Cell International, Inc.
BioReliance Corporation
SGA SA
Goodwin Biotechnology Inc.
Charles River Laboratories
Sartorius AG
REPROCELL Inc.
WuXi AppTec co. ltd
Recent Developments in the Market:
In February 2021, Cryo-Cell International, Inc.- a private cord blood bank announced that the company entered into a collaborative license agreement with Duke University. The primary objective of this agreement is to expand its major business units.
.
Global Cell Banking Outsourcing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Bank Type, Cell Type, Phase Outlook, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Bank Type:
Master Cell Banking
Working Cell Banking
Viral Cell Banking
By Cell Type:
Stem Cell Banking
Non-Stem Cell Banking
By Phase Outlook:
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Cell Banking Outsourcing Market, by Region, 2019-2029 (USD Million)
1.2.2. Cell Banking Outsourcing Market, by Bank Type, 2019-2029 (USD Million)
1.2.3. Cell Banking Outsourcing Market, by Cell Type, 2019-2029 (USD Million)
1.2.4. Cell Banking Outsourcing Market, by Phase Outlook, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Banking Outsourcing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Banking Outsourcing Market Dynamics
3.1. Cell Banking Outsourcing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing number of favorable government initiatives
3.1.1.2. Growing investments in drug and vaccine development
3.1.2. Market Challenges
3.1.2.1. High storage cost
3.1.3. Market Opportunities
3.1.3.1. Growing research and development activities
3.1.3.2. Increasing approvals for cell therapies
Chapter 4. Global Cell Banking Outsourcing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cell Banking Outsourcing Market, by Bank Type
6.1. Market Snapshot
6.2. Global Cell Banking Outsourcing Market by Bank Type, Performance – Potential Analysis
6.3. Global Cell Banking Outsourcing Market Estimates & Forecasts by Bank Type 2019-2029 (USD Million)
6.4. Cell Banking Outsourcing Market, Sub Segment Analysis
6.4.1. Master Cell Banking
6.4.2. Working Cell Banking
6.4.3. Viral Cell Banking
Chapter 7. Global Cell Banking Outsourcing Market, by Cell Type
7.1. Market Snapshot
7.2. Global Cell Banking Outsourcing Market by Cell Type, Performance – Potential Analysis
7.3. Global Cell Banking Outsourcing Market Estimates & Forecasts by Cell Type 2019-2029 (USD Million)
7.4. Cell Banking Outsourcing Market, Sub Segment Analysis
7.4.1. Stem Cell Banking
7.4.2. Non-Stem Cell Banking
Chapter 8. Global Cell Banking Outsourcing Market, by Phase Outlook
8.1. Market Snapshot
8.2. Global Cell Banking Outsourcing Market by Phase Outlook, Performance – Potential Analysis
8.3. Global Cell Banking Outsourcing Market Estimates & Forecasts by Phase Outlook 2019-2029 (USD Million)
8.4. Cell Banking Outsourcing Market, Sub Segment Analysis
8.4.1. Cell Bank Storage
8.4.2. Bank Characterization and Testing
8.4.3. Cell Bank Preparation
Chapter 9. Global Cell Banking Outsourcing Market, Regional Analysis
9.1. Cell Banking Outsourcing Market, Regional Market Snapshot
9.2. North America Cell Banking Outsourcing Market
9.2.1. U.S. Cell Banking Outsourcing Market
9.2.1.1. Bank Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Cell Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Phase Outlook breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Cell Banking Outsourcing Market
9.3. Europe Cell Banking Outsourcing Market Snapshot
9.3.1. U.K. Cell Banking Outsourcing Market
9.3.2. Germany Cell Banking Outsourcing Market
9.3.3. France Cell Banking Outsourcing Market
9.3.4. Spain Cell Banking Outsourcing Market
9.3.5. Italy Cell Banking Outsourcing Market
9.3.6. Rest of Europe Cell Banking Outsourcing Market
9.4. Asia-Pacific Cell Banking Outsourcing Market Snapshot
9.4.1. China Cell Banking Outsourcing Market
9.4.2. India Cell Banking Outsourcing Market
9.4.3. Japan Cell Banking Outsourcing Market
9.4.4. Australia Cell Banking Outsourcing Market
9.4.5. South Korea Cell Banking Outsourcing Market
9.4.6. Rest of Asia Pacific Cell Banking Outsourcing Market
9.5. Latin America Cell Banking Outsourcing Market Snapshot
9.5.1. Brazil Cell Banking Outsourcing Market
9.5.2. Mexico Cell Banking Outsourcing Market
9.5.3. Rest of Latin America Cell Banking Outsourcing Market
9.6. Rest of The World Cell Banking Outsourcing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Tran-Scell Biologics Pvt Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. LifeCell International Pvt. Ltd
10.2.3. Cryo-Cell International, Inc.
10.2.4. BioReliance Corporation
10.2.5. SGA SA
10.2.6. Goodwin Biotechnology Inc.
10.2.7. Charles River Laboratories
10.2.8. Sartorius AG
10.2.9. REPROCELL Inc.
10.2.10. WuXi AppTec co. ltd
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
